7 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
Selected Oral Antibacterial Agents With Excellent Oral Bioavailability Commonly Used to Treat Patients With Native Vertebral
With Excellent Oral ... #Antibiotics #Osteomyelitis ... #management #treatment ... #pharmacology # ... idsa
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... out of favor for C.diff ... Anaerobic #Bacteria #Pharmacology ... #Table #Susceptibility ... #Coverage #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mucoadhesive buccal tablet ... chew, or crush tablet ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
For my UME micro course, I made a figure that captures this terminology and lets learners
will represent antibiotics ... I’ve drawn the broad ... #antibiogram #pharmacology ... #management #spectrum ... #table #sensitivities
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
× 10 days #CDiff ... options #treatment #management ... #pharmacology # ... idsa #table
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Please refer to the table ... Tuberculosis #TB #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology